Stay updated on XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial
Sign up to get notified when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.

Latest updates to the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page
- Check6 days agoChange DetectedA sitewide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov error page. The displayed site revision also changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe footer displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check34 days agoChange DetectedThe page now shows a 403 Forbidden error with a minimal header and a Home link, replacing the previous study content. This indicates the study record is currently inaccessible.SummaryDifference20%

- Check41 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This reflects an underlying update to the page version behind the study details.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page footer revision indicator was updated from v3.6.5 to v3.6.6. This reflects a minor page update without changing core content or study details.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page's revision tag has been updated from v3.6.4 to v3.6.5, indicating a minor update to the site's revision history. This change appears to be administrative and does not modify the visible content of the study page.SummaryDifference0.1%

Stay in the know with updates to XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.